Close



Apr 22, 2024 08:01AM
Apr 22, 2024 08:00AM
Apr 8, 2024 08:00AM
Apr 8, 2024 08:00AM
Mar 28, 2024 04:01PM
Mar 26, 2024 04:01PM
Mar 13, 2024 08:00AM INmune Bio CSO and Co-Founder Mark Lowdell, Ph.D. Receives The ISCT Career Achievement Award in Cell and Gene Therapy
Mar 5, 2024 08:05AM
Mar 5, 2024 08:00AM
Feb 12, 2024 09:00AM
Feb 6, 2024 09:00AM
Jan 30, 2024 08:00AM
Jan 30, 2024 08:00AM
Jan 2, 2024 08:00AM INmune Bio Announces First Patient Dosed in a Phase 1/2 Study of INKmune™ in Patients with Metastatic Castration-Resistant Prostate Cancer
Jan 2, 2024 08:00AM
Dec 18, 2023 04:01PM
Dec 18, 2023 04:01PM
Nov 29, 2023 08:06AM
Nov 29, 2023 08:00AM
Nov 27, 2023 08:03AM
Nov 27, 2023 08:00AM INmune Bio Receives EMA’s Authorization in France and Spain for Phase II Clinical Trial of XPro™ for Early Alzheimer’s Disease
Nov 15, 2023 09:01AM
Nov 15, 2023 09:00AM
Nov 1, 2023 04:10PM
Oct 31, 2023 08:00AM
Oct 30, 2023 09:07AM
Oct 17, 2023 08:00AM
Oct 17, 2023 08:00AM INmune Bio Inc. Presents New Biomarker and Feasibility Data from Phase 1b Study Supporting the Use of XPro™ to Treat Alzheimer’s Disease at Clinical Trials on Alzheimer’s Disease (CTAD) Conferen
Oct 16, 2023 09:00AM
Sep 7, 2023 09:00AM
Sep 5, 2023 08:02AM
Sep 5, 2023 08:00AM
Aug 7, 2023 04:00PM
Aug 1, 2023 08:00AM
Jul 31, 2023 08:00AM INmune Bio, Inc. to Report Second Quarter 2023 Financial Results and Provide a Corporate Update on Monday, August 7
Jul 12, 2023 08:00AM
Jul 11, 2023 08:00AM
Jul 10, 2023 04:00PM
Jun 1, 2023 06:33AM
May 24, 2023 09:00AM
May 24, 2023 09:00AM
May 8, 2023 08:04AM INmune Bio (INMB) Announces FDA Clearance of IND Application for INKmune, a Natural Killer Therapy, for a Phase I/II Trial in Metastatic Castration-Resistant Prostate Cancer
May 8, 2023 08:00AM
May 3, 2023 04:10PM
Apr 24, 2023 09:00AM
Apr 24, 2023 09:00AM
Apr 19, 2023 08:30AM
Apr 19, 2023 08:30AM
Apr 11, 2023 08:00AM INmune Bio, Inc. to Present Preclinical Data at the 2023 AACR Annual Meeting Showing Improved Outcomes in High-Risk Breast Cancer by Targeting MUC4 Expression with INB03
Apr 11, 2023 08:00AM

251,551 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All